Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
On Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, offloading a substantial number of shares in Tesla Inc (NASDAQ:TSLA) and scooping up a hefty stake in Palantir Technologies Inc (NYSE:PLTR).
The Tesla Trade
Ark Invest reduced its stake in Tesla across two of its ETFs — ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW). The firm sold 56,425 and 6,442 shares respectively, the transaction was valued at $14.54 million. On Tuesday, Tesla shares closed 10.2% higher at $231.26, driven higher by the second-quarter delivery report of the company. The numbers came ahead of the consensus estimate.
This move comes despite Wood’s previous statements, where she referred to the Elon Musk-led automaker as the “biggest AI project” in the world and predicted the stock to reach $2,000 per share in the coming years.
As recently as June, Ark Invest set a new price target for Tesla at $2,600 for 2029, heavily revolving around the company’s autonomous vehicle ambitions.
The Palantir Trade
On the same day, Ark Invest, through its ARK Autonomous Technology & Robotics ETF (BATS:ARKQ), purchased 37,053 shares of Palantir worth $957,078.
This investment comes as the AI sector gains momentum, with Palantir being described as the “Messi of AI,” and “probably the most underestimated AI play, maybe tech play, in the market today” by Dan Ives, the managing director at Wedbush.
Notably, Ark Invest picked up Palantir shares worth $5.16 million just a day earlier.
See Also: This Cannabis Company Unveils Unique Findings At Germany
Other Key Trades:
- Ark Invest sold shares of Teladoc Health Inc (NYSE:TDOC) from its ARKF ETF.
- The firm also sold shares of Twist Bioscience Corp (NASDAQ:TWST) from its ARKG ETF.
- Ark Invest bought shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) and shares of Intellia Therapeutics Inc (NASDAQ:NTLA) for its ARKG ETF.
Read Next:
This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal